Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1617
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19303799 | PHARMACEUTICAL COMPOSITIONS | Non-Final OA | CALLIDITAS THERAPEUTICS AB |
| 18417024 | INJECTABLE PROLONGED-RELEASE HYDROGEL FORMULATIONS OF TOLL-LIKE RECEPTOR AGONISTS FOR INTRATUMORAL INJECTION TO INCREASE IMMUNOTHERAPY RESPONSE | Non-Final OA | The General Hospital Corporation |
| 18516382 | COMPOSITIONS AND METHODS FOR SCARLESS WOUND HEALING IN DIABETES | Non-Final OA | Washington University |
| 18278688 | NEURAL CONTROL OF ADAPTIVE IMMUNITY | Non-Final OA | The Feinstein Institutes for Medical Research |
| 18333283 | COMPOSITE FIBER SPONGE CONTAINING SULFORAPHANE | Non-Final OA | National Yang Ming Chiao Tung University |
| 18561804 | HPV INFECTIOUS DISEASE VACCINE | Non-Final OA | DAIICHI SANKYO COMPANY, LIMITED |
| 18345514 | TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS | Non-Final OA | Perfuse Therapeutics, Inc. |
| 18244569 | LONG COVID MEDICATION AND METHOD OF TREATMENT | Non-Final OA | KIRSCHNER, ELLEN |
| 17441162 | EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF | Non-Final OA | LONZA SALES AG |
| 18330912 | ANTIBIOTIC ADJUVANTS FOR GRAM NEGATIVE BACTERIA | Non-Final OA | San Jose State University Research Foundation |
| 18276761 | YEAST GLUCANS, METHODS AND USES THEREOF | Non-Final OA | Amyris Bio Products Portugal, Unipessoal LDA |
| 18269216 | A PROCESS OF PREPARATION OF FLOUR MIX AND ITS USE FOR THE TREATMENT OF DIABETES | Non-Final OA | DR DOZO LABORATORIES |
| 18039255 | COMPOSITION INCLUDING FRACTION OF SYZYGIUM FORMOSUM EXTRACT AS ACTIVE INGREDIENT | Non-Final OA | CARBOEXPERT INC. |
| 18035640 | POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS | Non-Final OA | NDPD PHARMA, INC. |
| 18154304 | CONTROLLED RELEASE VACCINE FORMULATION | Non-Final OA | Phibro Animal Health Corporation |
| 17970906 | COMPOSITIONS AND METHODS FOR TREATING BIOFILMS | Final Rejection | WIAB WATER INNOVATION AB |
| 17710929 | COMPOSITIONS COMPRISING PLANT-DERIVED EXOSOME-LIKE NANOVESICLES OR EXOSOMES AND METHODS OF USE THEREOF | Final Rejection | Nutraceutical Wellness Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy